Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. HOOD
9. DFTX
10. IBM

Go back to Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus

Medifast (MED) Buy Reiterated At DA Davidson, Buy Ahead Of Earnings

February 25, 2019 9:05 AM EST

DA Davidson analyst, Linda Bolton Weiser, reiterated her Buy rating on shares of Medifast (NYSE: MED) and suggests buying shares ahead of 4Q18 results on Tuesday, February
26th after the close. The company reaffirmed its 2018 guidance for revenue of $492.5M-
$497.5M... More